Association of Clozapine-Induced Weight Gain With a Polymorphism in the Leptin Promoter Region in Patients With Chronic Schizophrenia in a Chinese Population

Weight gain is a problem commonly encountered with antipsychotic treatment and has become more apparent with increasing use of the newer atypical antipsychotics. The adipocyte-derived hormone, leptin, has been associated with body weight and energy homeostasis, and abnormal regulation of leptin could play a role in weight gain induced by antipsychotics. We investigated whether a leptin gene promoter variant affected weight gain after long-term treatment with clozapine in chronic schizophrenia. Leptin G2548A polymorphism was genotyped in 102 Chinese Han inpatients with chronic schizophrenia treated with clozapine. Weight gains, expressed as change in body mass index (BMI), were monitored after long-term clozapine treatment. We found a significant relationship between the 3 leptin G/A genotypes and mean BMI gain (F2,99 = 3.35, P = 0.039, r2 = 0.09). Moreover, genotype had a strong effect on BMI gain in male (P = 0.004, r2 = 0.16), but not in female patients (P > 0.05). Thus, variation in the leptin gene may be a risk factor for weight gain in male patients with schizophrenia on long-term clozapine treatment.

[1]  A. Goudie,et al.  Antipsychotic‐induced weight gain , 2005, Diabetes, obesity & metabolism.

[2]  G. Reynolds,et al.  The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3]  Del D. Miller,et al.  Weight gain associated with the −759C/T polymorphism of the 5HT2C receptor and olanzapine , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[4]  G. Reynolds,et al.  Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis , 2005, Pharmacogenetics and genomics.

[5]  Del D. Miller,et al.  Clozapine‐induced weight gain associated with the 5HT2C receptor −759C/T polymorphism , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[6]  M. Seeman,et al.  Gender differences in the prescribing of antipsychotic drugs. , 2004, The American journal of psychiatry.

[7]  A. Malhotra,et al.  Pharmacogenetics of antipsychotic-induced weight gain , 2004, Psychopharmacology.

[8]  J. Ananth,et al.  A typical Antipsychotic Induced Weight Gain: Pathophysiology and Management , 2004 .

[9]  Zhi-jun Zhang,et al.  [Association of -2548G/A functional polymorphism in the promoter region of leptin gene with antipsychotic agent-induced weight gain]. , 2003, Zhonghua yi xue za zhi.

[10]  M. Atmaca,et al.  Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics. , 2003, The Journal of clinical psychiatry.

[11]  K. Cianflone,et al.  Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. , 2003, The Journal of clinical endocrinology and metabolism.

[12]  G. Reynolds,et al.  Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain. , 2003, The American journal of psychiatry.

[13]  H. Nasrallah.  A review of the effect of atypical antipsychotics on weight , 2003, Psychoneuroendocrinology.

[14]  E. Ravussin,et al.  The Gln223Arg polymorphism of the leptin receptor in Pima Indians: influence on energy expenditure, physical activity and lipid metabolism , 2002, International Journal of Obesity.

[15]  H. Meltzer,et al.  −759C/genetic variation of 5HT2C receptor and clozapine-induced weight gain , 2002, The Lancet.

[16]  S. Mottagui-Tabar,et al.  A Polymorphism in the Leptin Promoter Region (-2548 G/A) Influences Gene Expression and Adipose Tissue Secretion of Leptin , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[17]  U. Werneke,et al.  Options for pharmacological management of obesity in patients treated with atypical antipsychotics , 2002, International clinical psychopharmacology.

[18]  G. Reynolds,et al.  Association of antipsychotic druginduced weight gain with a 5-HT2C receptor gene polymorphism , 2002, The Lancet.

[19]  S. O’Rahilly,et al.  Metabolism: Partial leptin deficiency and human adiposity , 2001, Nature.

[20]  T. Olsson,et al.  Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics. , 2001, The Journal of clinical psychiatry.

[21]  W. Fleischhacker,et al.  Association of olanzapine-induced weight gain with an increase in body fat. , 2001, The American journal of psychiatry.

[22]  D. Allison,et al.  Antipsychotic-induced weight gain: a review of the literature. , 2001, The Journal of clinical psychiatry.

[23]  S. Zorn,et al.  The pharmacology of weight gain with antipsychotics. , 2001, The Journal of clinical psychiatry.

[24]  T. Pollmächer,et al.  Low Leptin Levels but Norma Body Mass Indices in Patients with Depression or Schizophrenia , 2001, Neuroendocrinology.

[25]  K. Brismar,et al.  Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. , 2000, The Journal of clinical psychiatry.

[26]  G. Siest,et al.  Association of the G‐2548A polymorphism in the 5′ region of the LEP gene with overweight , 2000, Annals of human genetics.

[27]  G. Siest,et al.  Association of the G-2548A polymorphism in the 5' region of the LEP gene with overweight. , 2000 .

[28]  M. Heo,et al.  Antipsychotic-induced weight gain: a comprehensive research synthesis. , 1999, The American journal of psychiatry.

[29]  T. Baptista.  Body weight gain induced by antipsychotic drugs: mechanisms and management , 1999, Acta psychiatrica Scandinavica.

[30]  C. Mantzoros.  The Role of Leptin in Human Obesity and Disease: A Review of Current Evidence , 1999, Annals of Internal Medicine.

[31]  V. Large,et al.  The different effects of a Gln27Glu β2‐adrenoceptor gene polymorphism on obesity in males and in females , 1999, Journal of internal medicine.

[32]  T. Pollmächer,et al.  Body weight and leptin plasma levels during treatment with antipsychotic drugs. , 1999, The American journal of psychiatry.

[33]  A. Strosberg,et al.  A leptin missense mutation associated with hypogonadism and morbid obesity , 1998, Nature Genetics.

[34]  M. Heo,et al.  Meta-analysis of linkage data under worst-case conditions: a demonstration using the human OB region. , 1998, Genetics.

[35]  S. O’Rahilly,et al.  Congenital leptin deficiency is associated with severe early-onset obesity in humans , 1997, Nature.

[36]  J. Friedman,et al.  Abnormal splicing of the leptin receptor in diabetic mice , 1996, Nature.

[37]  M. Pelleymounter,et al.  Effects of the obese gene product on body weight regulation in ob/ob mice. , 1995, Science.

[38]  R. Devos,et al.  Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.

[39]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[40]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[41]  D. Dwyer,et al.  Mechanistic connections between glucose/lipid disturbances and weight gain induced by antipsychotic drugs. , 2005, International review of neurobiology.

[42]  J. Ananth,et al.  Atypical antipsychotic induced weight gain: pathophysiology and management. , 2004, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[43]  H. Meltzer,et al.  759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain. , 2002, Lancet.

[44]  J. Lieberman,et al.  Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle. , 2001, The Journal of clinical psychiatry.

[45]  G. Blackburn,et al.  Weight gain and antipsychotic medication. , 2000, The Journal of clinical psychiatry.

[46]  J. Hebebrand,et al.  Serum leptin levels increase rapidly after initiation of clozapine therapy , 1998, Molecular Psychiatry.

[47]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.